| J0897 | Injection, denosumab, 1 mg | 26,220 | $20 | $472K |
| J3262 | Injection, tocilizumab, 1 mg | 40,950 | $10 | $204.8K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 5,200 | $30 | $166.4K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 17,640 | $10 | $141.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,300 | $110 | $139.4K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,060 | $30 | $53.6K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 270 | $140 | $37K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 470 | $70 | $33.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 240 | $130 | $30.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 350 | $80 | $26.5K |